Infectious disease · Phase II

Top sponsors

• BRIGHT MINDS BIOSCIENCES 27 programs
• United Therapeutics Europe 23 programs
• Chinese Academy of 16 programs
• Takeda 16 programs
• Vir Biotechnology 15 programs
• Vertex Pharmaceuticals (Australia) 12 programs
• Sinovac Research and 11 programs
• GSK Glaxo Smith 10 programs
• ENANTA PHARMACEUTICALS 8 programs
• Arrowhead Pharmaceuticals Ireland 7 programs
• Regeneron UK 7 programs
• Anaxis Pharma 6 programs

1. TOPIRAMATE

   Disc Medicine

   human immunodeficiency virus 1 (HIV-1)

   phase 2 · small molecule · active

   1 trial →

2. TVB-2640

   Sagimet Biosciences

   Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease

   phase 2 · small molecule · completed

   1 trial →

3. TVB-2640 25 mg (US)

   Sagimet Biosciences

   MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

   phase 2 · small molecule · completed

   1 trial →

4. Tafenoquine Oral Tablet

   60 DEGREES PHARMACEUTICALS, INC.

   COVID 19 Disease

   phase 2 · small molecule · completed

   1 trial →

5. Telaprevir

   Vertex Pharmaceuticals (Australia) Pty.

   Chronic Hepatitis C

   phase 2 · small molecule · completed

   1 trial →

6. Telaprevir and Sofosbuvir

   Vertex Pharmaceuticals (Australia) Pty.

   Hepatitis C, Chronic

   phase 2 · small molecule · completed

   1 trial →

7. Telavancin

   Theravance Biopharma Ireland Umited

   Infection

   phase 2 · small molecule · completed

   1 trial →

8. Telavancin

   CUMBERLAND PHARMACEUTICALS INC

   Gram-Positive Bacterial Infections

   phase 2 · small molecule · terminated

   2 trials →

9. Telavancin

   CUMBERLAND PHARMACEUTICALS INC

   Infections, Gram-Positive Bacterial

   phase 2 · small molecule · completed

   2 trials →

10. Tenofovir Alafenamide

    Vir Biotechnology

    Chronic Hepatitis B

    phase 2 · small molecule · completed

    1 trial →

11. Tenofovir gel

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 · small molecule · completed

    1 trial →

12. Tenofovir/lamivudine/lopinavir-ritonavir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV

    phase 2 · small molecule · completed

    1 trial →

13. Theory-based counseling program

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 2 · other · completed

    1 trial →

14. Tipranavir

    Boehringer Ingelheim

    HIV Infections

    phase 2 · small molecule · completed

    1 trial →

15. UB-421

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV-1-infection

    phase 2 · mab · active

    1 trial →

16. UB-421(25 mg/kg) Q2W

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV-1-infection

    phase 2 · mab · active

    1 trial →

17. UB-421(25 mg/kg) Q2W

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 2 · mab · completed

    1 trial →

18. UB-612

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 · mab · completed

    4 trials →

19. UBT251

    United Therapeutics Europe Ltd

    Metabolic Dysfunction-associated Steatohepatitis (MASH)

    phase 2 · small molecule · active

    1 trial →

20. UC-MSCs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cirrhosis Due to Hepatitis B

    phase 2 · mab · active

    1 trial →

21. UK-453,061 Dose 1

    Pfizer

    HIV-1

    phase 2 · small molecule · terminated

    1 trial →

22. Ursodeoxycholic acid

    Hospital Authority, Hong Kong

    Hepatitis D

    phase 2 · small molecule · active

    1 trial →

23. Ursodeoxycholic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 · small molecule · completed

    1 trial →

24. VAC059

    United Therapeutics Europe Ltd

    Plasmodium Falciparum Malaria

    phase 2 · mab · completed

    1 trial →

25. VBR

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 · small molecule · terminated

    1 trial →

26. VCH-222 or matching placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 2 · small molecule · completed

    1 trial →

27. VCH-759 (BCH-27759)

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C, Chronic

    phase 2 · small molecule · completed

    1 trial →

28. VIR-2218

    Alnylam Netherlands B.V.

    Hepatitis B, Chronic

    phase 2 · small molecule · completed

    1 trial →

29. VIR-2218

    Vir Biotechnology

    Hepatitis D, Chronic

    phase 2 · small molecule · active

    1 trial →

30. VIR-2218

    Vir Biotechnology

    Hepatitis B, Chronic

    phase 2 · small molecule · completed

    1 trial →

31. VIR-2218

    Alnylam Netherlands B.V.

    Chronic Hepatitis B

    phase 2 · small molecule · completed

    2 trials →

32. VIR-2218

    Vir Biotechnology

    Chronic Hepatitis B

    phase 2 · small molecule · completed

    1 trial →

33. VIR-2218-1006

    Vir Biotechnology

    Chronic Hepatitis B Virus Infection

    phase 2 · small molecule · active

    1 trial →

34. VIR-3434

    Vir Biotechnology

    Hepatitis B, Chronic

    phase 2 · small molecule · completed

    1 trial →

35. VIR-3434, VIR-2218

    Vir Biotechnology

    Chronic Hepatitis D Virus (HDV) Infection

    phase 2 · small molecule · active

    1 trial →

36. VIR-CHDV-V206

    Vir Biotechnology

    Chronic Hepatitis D Virus (HDV) Infection

    phase 2 · small molecule · active

    1 trial →

37. VIR-MHB1-V200

    Vir Biotechnology

    Chronic Hepatitis B Virus (HBV) Infection

    phase 2 · small molecule · active

    1 trial →

38. VK2809

    Viking Therapeutics

    NASH - Nonalcoholic Steatohepatitis

    phase 2 · small molecule · completed

    1 trial →

39. VLA2001

    United Therapeutics Europe Ltd

    SARS-CoV-2 Virus Infection

    phase 2 · mab · completed

    1 trial →

40. VMP001

    United Therapeutics Europe Ltd

    Malaria

    phase 2 · mab · completed

    1 trial →

41. VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 · small molecule · completed

    1 trial →

42. VP20621

    Takeda

    Clostridium Difficile Infection

    phase 2 · mab · completed

    1 trial →

43. VRC-HIVDNA016-00-VP

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 · mab · completed

    1 trial →

44. VX-135

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 2 · small molecule · completed

    3 trials →

45. VX-222

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C Virus

    phase 2 · small molecule · completed

    2 trials →

46. VX-950

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 2 · small molecule · completed

    2 trials →

47. Vaborem 1 g/1 g powder for concentrate for solution for infusion

    A.Menarini Australia Pty Limited

    Suspected or confirmed Gram negative infections

    phase 2 · small molecule · active

    1 trial →

48. Vaccine PvCS N+C+R

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria

    phase 2 · mab · completed

    1 trial →

Frequently asked questions